DexCom, Inc. vs KraneShares CSI China Internet ETF — how do they compare? DexCom, Inc. trades at $84.38 (market cap $31.86B), while KraneShares CSI China Internet ETF trades at $24.49 (market cap $4.37B). The key difference: DexCom, Inc. is far larger — about 7.3× KraneShares CSI China Internet ETF's market cap, and DexCom, Inc. is trading nearer its 52-week high, KraneShares CSI China Internet ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and KraneShares CSI China Internet ETF for 57 Days on average.
| DXCM | KWEB | |
|---|---|---|
Market Cap | $31.86B | $4.37B |
Volume | 3,607,070 | 13,393,361 |
Sector | Health | Sector/Thematic |
52-Week High | $92.34 | $41.35 |
52-Week Low | $54.84 | $23.63 |
Typical Hold Time | 62 Days | 57 Days |
Enterprise Value | $31.32B | — |
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $84.3, up 1.09% today, with a bearish technical signal but strong fundamentals. Revenue grew to $4.66B in 2025, with net income of $836.3M and a 17.93% margin. The stock has a P/E of 33.32 and P/S of 6.74. Recent news highlights growth in CGM adoption for Type 2 diabetes. Analyst consensus is bullish with an average price target of $95.07, supported by 42 buy ratings.
Outlook remains positive due to earnings beats and market expansion, but risks include competition and reimbursement challenges. The stock offers growth potential, yet investors should monitor execution against high valuations and technical resistance near $85.
KWEB trades at $24.33, down 0.86% with a bearish technical signal. Moving averages indicate selling pressure, while oscillators are neutral. Support and resistance cluster around $24-$25. Recent news highlights U.S.-China trade dynamics and institutional stake changes, with mixed sentiment on Chinese internet stocks amid economic rebalancing talks.
The outlook remains cautious due to geopolitical risks and weak technicals. Opportunities exist if trade tensions ease, but risks include Chinese regulatory shifts and global protectionism. Investor sentiment is divided, with some institutions reducing exposure while others accumulate, reflecting uncertainty in China's economic trajectory.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.
Read more on KWEB →